Javice remains free pending sentencing in a $175M fraud against JPMorgan. Her lawyer says an ankle monitor would make ...
J.P. Morgan analyst Jeremy Tonet remains constructive on the power sector, viewing it as “washed out” despite current bearish ...
We recently published a list of Jim Cramer Discusses These 7 Stocks & Is Sick And Tired Of Negativity. In this article, we ...
Following Nvidia's (NVDA) recent announcement at GTC 2025 that it plans to scale artificial intelligence factories with ...
Mitsubishi UFJ Trust & Banking Corp lessened its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 6.0% in the 4th ...
UNIVEST FINANCIAL Corp cut its holdings in JPMorgan Chase & Co. (NYSE:JPM) by 0.7% during the 4th quarter, according to its ...
Explore more
There’s a known phrase – “fake it till you make it”? And it looks like Charlie Javice might’ve taken that a bit too literally ...
Hedge funds last week ditched tech stocks at the fastest pace in six months and at the highest levels in five years, according to Goldman Sachs , as world markets tumbled on worries over U.S.
As of March 25, Amazon’s stock closed at approximately $205.73, a 13% increase over the past year. Market analyst Jim Cramer ...
Charlie Javice, the founder of the student aid startup Frank, has been convicted of defrauding JP Morgan Chase of $175 ...
Discover predictions for upcoming dividend increases from top companies with long-term growth. Learn which stocks to watch ...
JP Morgan's survey of endocrinologists finds strong awareness of Crinetics' atumelnant, with positive efficacy impressions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results